BeOne Medicines
Jeremy Thompson, MBA, currently serves as the National Director of Field Reimbursement at BeiGene, starting in March 2024. Prior to this role, Jeremy was with Novartis from November 2020 to January 2024, where a focus was placed on accelerating innovation in digital health solutions and managing strategic partnerships with a budget exceeding $1 billion. Jeremy's extensive experience at Genentech from March 2006 to November 2020 encompasses roles in reimbursement strategy, operations management, and sales management in oncology and neurology products. Jeremy holds an MBA in General Management and a BS in Chemistry from Tennessee Technological University.
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.